Literature DB >> 3365082

Gastritis and Campylobacter pylori in healthy, asymptomatic volunteers.

J S Barthel1, T U Westblom, A D Havey, F Gonzalez, E D Everett.   

Abstract

A high prevalence of histologic gastritis in asymptomatic individuals has been reported in the literature. The studies have been poorly controlled for gastritis risk factors. We evaluated 20 healthy, asymptomatic volunteers free of known risk factors for gastritis with endoscopy, mucosal biopsy, culture, and gastric pH determination. The prevalence of gastritis on histologic examination was found to be 20%. There was no relationship between the presence of macroscopic findings at endoscopy and the presence of histologic gastritis. In all instances where histologic gastritis was documented, Campylobacter pylori was observed in the gastric mucus. Mucosal tissue invasion by C pylori was not observed. The presence of gastritis and C pylori was associated with fasting hypochlorhydria. Follow-up evaluation was performed eight to 13 months after the initial endoscopic evaluation in three of the volunteers with positive test results. Persistence of C pylori and gastritis was observed. These findings suggest that histologic gastritis is common in healthy, asymptomatic individuals and is strongly associated with the presence of C pylori.

Entities:  

Mesh:

Year:  1988        PMID: 3365082

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  34 in total

1.  Helicobacter mustelae-induced gastritis and elevated gastric pH in the ferret (Mustela putorius furo).

Authors:  J G Fox; G Otto; N S Taylor; W Rosenblad; J C Murphy
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

2.  High prevalence of Helicobacter pylori infection and histologic gastritis in asymptomatic Hispanics.

Authors:  M Dehesa; C P Dooley; H Cohen; P L Fitzgibbons; G I Perez-Perez; M J Blaser
Journal:  J Clin Microbiol       Date:  1991-06       Impact factor: 5.948

Review 3.  Formulary management of antiulcer drugs: clinical considerations.

Authors:  S L Sankey; L S Friedman
Journal:  Pharmacoeconomics       Date:  1994-03       Impact factor: 4.981

4.  The prevalence of Campylobacter pylori gastritis among asymptomatic adults.

Authors:  D B Gregson; D E Low; M M Cohen; N B Cooter; J J Connon; S L Wolman; A E Simor
Journal:  CMAJ       Date:  1989-06-15       Impact factor: 8.262

5.  Gastric histology, serological markers and age as predictors of gastric acid secretion in patients infected with Helicobacter pylori.

Authors:  M H Derakhshan; E El-Omar; K Oien; D Gillen; V Fyfe; J E Crabtree; K E L McColl
Journal:  J Clin Pathol       Date:  2006-04-27       Impact factor: 3.411

Review 6.  Helicobacter pylori in gastroduodenal disease.

Authors:  R J Loffeld
Journal:  Pharm Weekbl Sci       Date:  1990-04-27

7.  Inappropriate hypergastrinaemia in asymptomatic healthy subjects infected with Helicobacter pylori.

Authors:  J T Smith; R E Pounder; C U Nwokolo; S Lanzon-Miller; D G Evans; D Y Graham; D J Evans
Journal:  Gut       Date:  1990-05       Impact factor: 23.059

8.  Pathological significance and molecular characterization of the vacuolating toxin gene of Helicobacter pylori.

Authors:  S H Phadnis; D Ilver; L Janzon; S Normark; T U Westblom
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

9.  Treatment of Helicobacter pylori-associated gastroduodenal disease in children. Clinical evaluation of antisecretory vs antibacterial therapy.

Authors:  C Rosioru; M S Glassman; S H Berezin; H E Bostwick; M Halata; S M Schwarz
Journal:  Dig Dis Sci       Date:  1993-01       Impact factor: 3.199

10.  High prevalence of Helicobacter pylori in liver cirrhosis: relationship with clinical and endoscopic features and the risk of peptic ulcer.

Authors:  S Siringo; D Vaira; M Menegatti; F Piscaglia; S Sofia; M Gaetani; M Miglioli; R Corinaldesi; L Bolondi
Journal:  Dig Dis Sci       Date:  1997-10       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.